Clinical Feasibility of NGS Liquid Biopsy Analysis in NSCLC Patients Using Oncomine Precision Assay with Genexus™ Integrated Sequencer

Clinical Feasibility of NGS Liquid Biopsy Analysis in NSCLC Patients Using Oncomine Precision Assay with Genexus™ Integrated Sequencer

Saved in:

Bibliographic Details
Main Authors:	S. Buglioni, E. Gallo, C. Ercolani, F. Rollo, L. Ronchetti, A. Palange, G. Americi, A. Di Benedetto, V. Di Noia, P. Visca
Format:	Article
Language:	English
Published:	Elsevier 2023-11-01
Series:	The Journal of Liquid Biopsy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2950195423000176
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genomic Profiling in NSCLC: Insights from Liquid Biopsy
by: C. Ercolani, et al.
Published: (2023-11-01)

Impact of Reference Materials for Analytical Performance Evaluation of Liquid Biopsy NGS Assays
by: A. Hallermayr, et al.
Published: (2023-11-01)

Plasma mutation profile of precursor lesions and colorectal cancer using the Oncomine Colon cfDNA Assay
by: Mariana Bisarro dos Reis, et al.
Published: (2024-12-01)

NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers
by: Michela Verzè, et al.
Published: (2024-06-01)

Mutational Prognosis of Survival by Liquid Biopsy in Advanced EGFRm NSCLC
by: M. Galvez-Nino, et al.
Published: (2023-11-01)

Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectives
by: Molly S.C. Li, et al.
Published: (2024-03-01)

Detecting gene copy number alterations by Oncomine Comprehensive genomic profiling in a comparative study on FFPE tumor samples
by: Fabio Bozzi, et al.
Published: (2025-02-01)

A Narrow NGS Panel in the Analysis of KRAS p.G12C Mutation in Longitudinal Series of NSCLC Patients: A Pilot Study
by: F. Pepe, et al.
Published: (2023-11-01)

NGS Testing on Plasma-based ctDNA Samples at Key Clinical Timepoints in Advanced NSCLC: Handling of Blood Samples and Real-World Experience
by: M. Verzè, et al.
Published: (2023-11-01)

On ƞǤ_Ş-Compactness
by: Ahmed Sh. Mohamed, et al.
Published: (2025-01-01)

Unlocking the promise of liquid biopsies in precision oncology
by: Alejandra Pando-Caciano, et al.
Published: (2024-03-01)

Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapy
by: Haolun Ding, et al.
Published: (2025-01-01)

Liquid Biopsy Analysis Shows MAGI2 Gene as Potential Negative Prognosis Biomarker in NSCLC Patients
by: P. Mediavilla, et al.
Published: (2023-11-01)

Comparison of the Impact of tNGS with mNGS on Antimicrobial Management in Patients with LRTIs: A Multicenter Retrospective Cohort Study
by: Li D, et al.
Published: (2025-01-01)

NGS sequencing in barley breeding and genetic studies
by: I. V. Rozanova, et al.
Published: (2020-07-01)

Liquid Biopsy-based Risk Stratification and Intensification of Treatment In EGFR Mutant Advanced NSCLC (L-BRITE)U
by: H. Baskarane, et al.
Published: (2023-11-01)

An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
by: Michele Massimino, et al.
Published: (2025-01-01)

Onco-mNGS facilitates rapid and precise identification of the etiology of fever of unknown origin: a single-centre prospective study in North China
by: Bingbing Liu, et al.
Published: (2024-12-01)

The role of mNGS in the diagnosis of talaromycosis and case series
by: Jing Zhao, et al.
Published: (2025-02-01)

Identification of PD1-mediated regulation of antitumor antigen response in patients with NSCLC using the trans vivo DTH assay
by: Ticiana Leal, et al.
Published: (2020-05-01)

Minimally invasive biopsy‐based diagnostics in support of precision cancer medicine
by: Bo Franzén, et al.
Published: (2024-11-01)

Circulating Tumor Cells of Non-small Cell Lung Cancer (NSCLC) Patients. A Potential New Liquid Biopsy Biomarker
by: E. Fernández Armúa, et al.
Published: (2023-11-01)

Survey of the Applications of NGS to Whole-Genome Sequencing and Expression Profiling
by: Jong-Sung Lim, et al.
Published: (2012-03-01)

Performance, evaluation and integration of tNGS in diagnostic workflow for tuberculosis
by: F. Stasi, et al.
Published: (2024-12-01)

Impact of PROphet Assay in Changing Physician’s Therapeutic Decision-Making for Checkpoint Immunotherapy in NSCLC (Non-Small Cell Lung Cancer)
by: D. Gandara, et al.
Published: (2023-11-01)

The role of liquid biopsy as a catalyst for sustained progress in precision oncology – Perspective of the young committee of the international society of liquid biopsy
by: Erick F. Saldanha, et al.
Published: (2024-09-01)

Roles of Tumor-Educated Platelets (TEPs) in the biology of Non-Small Cell Lung Cancer (NSCLC): A systematic review. “Re-discovering the neglected biosources of the liquid biopsy family”
by: Andrea Gottardo, et al.
Published: (2024-03-01)

NGS revolutionizing oral cancer: From genetic profiling to personalized therapy
by: Gayathri Rengasamy, et al.
Published: (2024-06-01)

The study of organelle DNA variability in alloplasmic barley lines in the NGS era
by: M. G. Siniauskaya, et al.
Published: (2020-03-01)

Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytology
by: Wiame Potonnier, et al.
Published: (2025-01-01)

Integrating Idylla TM Alongside Real-time PCR and NGS for Investigation of Gene Fusions in Pleural Effusions of Lung Adenocarcinoma
by: G. Lopez, et al.
Published: (2023-11-01)

Advancements in precision oncology: Investigating the function of circulating DNA in the advancement of liquid biopsy technologies
by: Stootee Baruah, et al.
Published: (2024-09-01)

Optimizing the NGS-based discrimination of multiple lung cancers from the perspective of evolution
by: Ziyang Wang, et al.
Published: (2025-01-01)

Case report: Rethinking NGS analysis in diagnosing Diamond-Blackfan anemia syndrome
by: Panayiota L. Papasavva, et al.
Published: (2024-11-01)

Molecular characteristics of NPM1 mutations in AML patients using targeted NGS
by: Reham AboElwafa, et al.
Published: (2024-12-01)

KRAS mutations in patients with AML: clinical characteristics and not reported mutations using NGS
by: Salma Said Ibrahim Elsayed, et al.
Published: (2024-12-01)

Harnessing liquid biopsies: Exosomes and ctDNA as minimally invasive biomarkers for precision cancer medicine
by: Oluwaseun Adebayo Bamodu, et al.
Published: (2023-12-01)

Comparison of mNGS with conventional methods for diagnosis of cryptococcal meningitis: a retrospective study
by: Zai-Jie Jiang, et al.
Published: (2025-01-01)

Exploring the appropriate situation of performing CSF mNGS in patients with proposed intracranial infections
by: Jinliang Deng, et al.
Published: (2024-11-01)

Phantom Limb Pain: Low Frequency Repetitive Transcranial Magnetic Stimulation in Unaffected Hemisphere
by: Andrea Di Rollo, et al.
Published: (2011-01-01)